نتایج جستجو برای: her2 receptors

تعداد نتایج: 236775  

2012
Yasuyuki Kojima Hiroko Tsunoda

Triple negative (TN) breast cancer is defined as cancer with negative expressions of hormone receptors and human epidermal growth factor receptor 2 (HER2). This subtype is characterized as a cancer with a high malignancy potential and a poor prognosis. Endocrine therapy and anti-HER2 therapy are ineffective in the treatment of TN breast cancer as they have less specific targets compared with ot...

Journal: :Molecular cancer therapeutics 2013
Bart S Hendriks Stephan G Klinz Joseph G Reynolds Christopher W Espelin Daniel F Gaddy Thomas J Wickham

Numerous targeted nanotherapeutics have been described for potential treatment of solid tumors. Although attention has focused on antigen selection and molecular design of these systems, there has been comparatively little study of how cellular heterogeneity influences interaction of targeted nanoparticles with tumor cells. Antigens, such as HER2/ERBB2, are heterogeneously expressed across diff...

2013
PAWEŁ KRAWCZYK MARCIN NICOŒ TOMASZ POWRÓZEK RADOSŁAW MLAK MAREK SAWICKI BOŻENA JAROSZ BEATA PAJĄK KRZYSZTOF KUCHARCZYK DARIUSZ STENCEL TOMASZ TROJANOWSKI JANUSZ MILANOWSKI

The HER2 (ErbB2/neu) protein is a member of the HER (ErbB) receptor family (EGFR, HER2, HER3 and HER4) that expresses tyrosine kinase activity in the intracellular domain. EGFR and HER2 overexpression is observed in numerous types of cancer, nevertheless, the susceptibility of patients with non-small cell lung cancer (NSCLC) to therapy with EGFR and HER2 tyrosine kinase inhibitors (TKIs) depend...

2013
Bart S. Hendriks Stephan G. Klinz Joseph G. Reynolds Christopher W. Espelin Daniel F. Gaddy Thomas J. Wickham

Numerous targeted nanotherapeutics have been described for potential treatment of solid tumors. Although attention has focused on antigen selection and molecular design of these systems, there has been comparatively little study of how cellular heterogeneity influences interaction of targeted nanoparticles with tumor cells. Antigens, such as HER2/ERBB2, are heterogeneously expressed across diff...

Journal: :British journal of neurosurgery 2011
Eman Abdelzaher Saba Mohamed El-Gendi Ahmed Yehya Ahmed Gaber Gowil

INTRODUCTION The biological behaviour of meningiomas and the risk of recurrence in individual cases cannot be predicted by using conventional histological criteria alone. A number of histologically benign meningiomas may recur, even after gross complete surgical removal. MATERIAL AND METHODS A retrospective immunohistochemical and statistical analysis of 60 patients with benign intracranial m...

2015
Susana Garcia-Recio Eva M. Pastor-Arroyo Mercedes Marín-Aguilera Vanessa Almendro Pedro Gascón Antimo Migliaccio

BACKGROUND Substance P (SP) is a pleiotropic cytokine/neuropeptide that enhances breast cancer (BC) aggressiveness by transactivating tyrosine kinase receptors like EGFR and HER2. We previously showed that SP and its cognate receptor NK-1 (SP/NK1-R) signaling modulates the basal phosphorylation of HER2 and EGFR in BC, increasing aggressiveness and drug resistance. In order to elucidate the mech...

Journal: :Molecular cancer therapeutics 2012
Hyun-Jin Nam Keith A Ching Julie Kan Hwang-Phill Kim Sae-Won Han Seock-Ah Im Tae-You Kim James G Christensen Do-Youn Oh Yung-Jue Bang

Recently, HER2-directed treatment, such as trastuzumab, has shown clinical benefit in HER2-amplified gastric cancer. On the basis of recent studies about epidermal growth factor receptor (EGFR) or HER2-targeting agents (including gefitinib, lapatinib, and trastuzumab) in gastric cancer, the potent effects of pan-HER inhibitors targeting the HER family are anticipated. In this study, we evaluate...

2018
Xiaolin Yu Sharad Ghamande Haitao Liu Lu Xue Shuhua Zhao Wenxi Tan Lijing Zhao Shou-Ching Tang Daqing Wu Hasan Korkaya Nita J. Maihle Hong Yan Liu

HER family members are interdependent and functionally compensatory. Simultaneously targeting EGFR/HER2/HER3 by antibody combinations has demonstrated superior treatment efficacy over targeting one HER receptor. However, antibody combinations have their limitations, with high immunogenicity and high cost. In this study, we have developed a three-in-one nucleic acid aptamer-small interfering RNA...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2013
C Denkert S Loibl R Kronenwett J Budczies C von Törne V Nekljudova S Darb-Esfahani C Solbach B V Sinn C Petry B M Müller J Hilfrich G Altmann A Staebler C Roth B Ataseven T Kirchner M Dietel M Untch G von Minckwitz

BACKGROUND Hormone and human epidermal growth factor receptor 2 (HER2) receptors are the most important breast cancer biomarkers, and additional objective and quantitative test methods such as messenger RNA (mRNA)-based quantitative analysis are urgently needed. In this study, we investigated the clinical validity of RT-PCR-based evaluation of estrogen receptor (ESR1) and HER2 mRNA expression. ...

2016
Debora de Melo Gagliato Denis Leonardo Fontes Jardim Mario Sergio Pereira Marchesi Gabriel N. Hortobagyi

Breast Cancer (BC) is a highly prevalent disease. A woman living in the United States has a 12.3% lifetime risk of being diagnosed with breast cancer [1]. It is the most common female cancer and the second most common cause of cancer death in women [2]. Of note, amplification or overexpression of Human Epidermal Receptor 2 (HER2) oncogene is present in approximately 18 to 20% of primary invasiv...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید